100 related articles for article (PubMed ID: 11824446)
21. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles.
Hernández ER; Gómez-Palomares JL; Ricciarelli E
Fertil Steril; 2009 Apr; 91(4 Suppl):1358-61. PubMed ID: 18555236
[TBL] [Abstract][Full Text] [Related]
22. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
23. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
[TBL] [Abstract][Full Text] [Related]
24. Follitropin-alpha (Gonal-F) versus follitropin-beta (Puregon) in controlled ovarian hyperstimulation for in vitro fertilization: is there any difference?
Orvieto R; Nahum R; Rabinson J; Ashkenazi J; Anteby EY; Meltcer S
Fertil Steril; 2009 Apr; 91(4 Suppl):1522-5. PubMed ID: 18851846
[TBL] [Abstract][Full Text] [Related]
25. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
[TBL] [Abstract][Full Text] [Related]
26. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
[TBL] [Abstract][Full Text] [Related]
27. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
de Mouzon J; Allavena E; Schmitt C; Frappé M
Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
[TBL] [Abstract][Full Text] [Related]
28. [Ovulation stimulation. Use and "abuse"].
Nilsson L; Bergh T; Jeppson S; Wramsby H
Lakartidningen; 1995 Feb; 92(7):635-7. PubMed ID: 7861857
[No Abstract] [Full Text] [Related]
29. A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome.
Kok JD; Looman CW; Weima SM; te Velde ER
Fertil Steril; 2006 Apr; 85(4):918-24. PubMed ID: 16580375
[TBL] [Abstract][Full Text] [Related]
30. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study.
Lavery SA; El-Shawarby SA; Turner C; Trew G
Fertil Steril; 2008 Nov; 90(5):1969-72. PubMed ID: 18166182
[TBL] [Abstract][Full Text] [Related]
31. [Results of in vitro fertilization in natural cycle or with mild stimulation].
Miserez Zaugg C ; Fournet Irion N ; Cantero-Perez P ; Streuli I
Rev Med Suisse; 2014 Oct; 10(447):1969-70, 1972-4, 1976. PubMed ID: 25518206
[TBL] [Abstract][Full Text] [Related]
32. Can we eliminate severe ovarian hyperstimulation syndrome?
Orvieto R
Hum Reprod; 2005 Feb; 20(2):320-2. PubMed ID: 15567876
[TBL] [Abstract][Full Text] [Related]
33. [The use of GnRH antagonists in ovarian stimulation for intrauterine inseminations: is there any interest?].
Pasquier M; Maitrot L; Leperlier F; Dehghani C; Snaifer E; Durnerin IC; Hugues JN
Gynecol Obstet Fertil; 2008 Jun; 36(6):644-9. PubMed ID: 18539072
[TBL] [Abstract][Full Text] [Related]
34. Clinical use of colony-stimulating factor-1 in ovulation induction for poor responders.
Takasaki A; Ohba T; Okamura Y; Honda R; Seki M; Tanaka N; Okamura H
Fertil Steril; 2008 Dec; 90(6):2287-90. PubMed ID: 18718581
[TBL] [Abstract][Full Text] [Related]
35. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
36. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R; Morris S
Fertil Steril; 2005 Jul; 84(1):93-8. PubMed ID: 16009163
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
Kumbak B; Kahraman S
Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
[TBL] [Abstract][Full Text] [Related]
38. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr.
Arslan M; Bocca S; Mirkin S; Barroso G; Stadtmauer L; Oehninger S
Fertil Steril; 2005 Sep; 84(3):555-69. PubMed ID: 16169382
[TBL] [Abstract][Full Text] [Related]
39. Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
Orvieto R; Rabinson J; Meltcer S; Gemer O; Anteby EY; Zohav E
Fertil Steril; 2008 Mar; 89(3):736-7. PubMed ID: 17498708
[TBL] [Abstract][Full Text] [Related]
40. Defining case-control studies.
Ntui A; Shendre A; Lee L; McGwin G
Fertil Steril; 2011 Jun; 95(8):e59; author reply e60. PubMed ID: 21536275
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
